Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Bacillus subtilis ComK negatively regulates degR gene expression

M Ogura1, T Tanaka

  • 1Department of Marine Science, School of Marine Science and Technology, Tokai University, Shimizu, Shizuoka, Japan.

Molecular & General Genetics : MGG
|March 26, 1997
PubMed
Summary

Bacillus subtilis degR gene expression is negatively controlled by ComK, which prevents sigmaD-driven transcription. MecA and MecB mutations relieve this repression, highlighting a novel regulatory pathway for exoprotease production.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Semiquantitative CLDN18 expression and clinical outcomes in patients with CLDN18-positive gastric cancer treated with zolbetuximab plus chemotherapy.

ESMO gastrointestinal oncology·2026
Same author

BevRam-GC01 study protocol: a phase I trial of bevacizumab plus ramucirumab and paclitaxel in advanced gastric cancer.

ESMO gastrointestinal oncology·2026
Same author

The clinical utility of an mGPS and SII combined score in patients with advanced gastric cancer treated with nivolumab monotherapy.

ESMO gastrointestinal oncology·2026
Same author

Real-world clinical impact of first-line immune checkpoint inhibitor-based therapy in advanced esophageal squamous cell carcinoma.

ESMO gastrointestinal oncology·2026
Same author

Clinical efficacy of nivolumab-based therapy for HER2-negative diffuse-type advanced gastric or gastroesophageal junction adenocarcinoma with peritoneal dissemination.

ESMO gastrointestinal oncology·2026
Same author

Managing zolbetuximab-induced nausea and vomiting: a proposal for a pragmatic approach in clinical practice.

ESMO gastrointestinal oncology·2026

Area of Science:

  • Molecular Biology
  • Microbial Genetics
  • Gene Regulation

Background:

  • Exoprotease production in Bacillus subtilis is primarily regulated by the DegS-DegU two-component system.
  • The degR gene product is a minor factor positively influencing exoprotease production in a DegS-DegU-dependent manner.
  • Previous studies indicated sigmaD as the alternative sigma factor responsible for degR transcription.

Purpose of the Study:

  • To elucidate the regulatory mechanism controlling degR gene transcription in Bacillus subtilis.
  • To investigate the roles of mecA, mecB, and comK genes in degR expression.
  • To understand how MecA, MecB, and ComK interact to modulate sigmaD-dependent transcription.

Main Methods:

  • Genetic analysis involving gene disruption (mutations) in Bacillus subtilis strains.

Related Experiment Videos

  • Analysis of degR gene transcription under different genetic conditions (mecA, mecB, comK disruptions).
  • Comparison of degR expression driven by native sigmaD-dependent and artificial sigmaA-dependent promoters.
  • Main Results:

    • Disruption of mecA or mecB prevented degR transcription, an effect relieved by further comK disruption.
    • The negative effect of mecA/B mutations on degR transcription is dependent on a specific upstream region (-52).
    • MecA/B mutations negatively regulate ComK, leading to enhanced comK expression, which in turn represses degR transcription via sigmaD.

    Conclusions:

    • ComK acts as a negative regulator of degR expression by inhibiting sigmaD-driven transcription.
    • The MecA and MecB proteins negatively regulate ComK, indirectly influencing degR expression.
    • This study reveals a novel regulatory cascade (MecA/B → ComK → sigmaD → degR) controlling exoprotease production in Bacillus subtilis.